MedTrace Logo

Dexmedetomidine and Pregabalin for Conscious Sedation During Cataract Surgery

NCT03735368 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-12-27

No results posted yet for this study

Summary

Although topical anesthesia by eye drops for cataract surgery is a non-invasive technique but it may provide insufficient anesthesia which requires the intraoperative use of additional topical local anesthetics and raises the need for sedation.

Conditions

  • Conscious Sedation

Interventions

DRUG

Dexmedetomidine Injection

Dexmedetomidine Injection 1 μg/kg then 0.5-1 μg/kg/h infusion

DRUG

Placebo oral capsule

placebo oral capsules

DRUG

Pregabalin Oral Capsule

150 mg pregabalin Oral Capsule

DRUG

topical anesthesia

topical anesthesia of the eye by Benoxinate Hydrochloride 0.4% Eye Drops

Sponsors & Collaborators

  • Abd-Elazeem Abd-Elhameed Elbakry

    lead OTHER

Principal Investigators

  • Abd-Elazeem A Elbakry, MD · Assistant professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-10
Primary Completion
2019-10-30
Completion
2019-11-29

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03735368 on ClinicalTrials.gov